AzTrials
AzTrials

Diabetes Mellitus, Type 1DI-CONCT02839031

Cognitive-Behavioral Therapy (CBT) in Children With Diabetes

A study testing "CBT" (Cognitive-Behavioral Therapy) in people with Diabetes Mellitus, Type 1, run by University Hospital, Montpellier at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Diabetes mellitus in children and adolescents is a source of stress and poor quality of life for themselves and their family. Development of adaptive coping strategies may be improved by focused parent and children training. Read more about this study

Who is it for?
Ages 6 to 18 years
Conditions the study is for
Diabetes Mellitus, Type 1
What is being tested?
"CBT" (Cognitive-Behavioral Therapy)
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
57 participants
Where
1 siteFrance
Study dates
11 Mar 2015to 1 Jul 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Children and teenagers from 6 years-old to 18 years-old
  • Having diabetes treated by insulin for at least 1 year
  • Followed in pediatric diabetology department of Arnaud de Villeneuve Hospital in University Hospital of Montpellier
  • Study Inform Consent signed by both children and parents

Who cannot join

  • Children with developmental delay, severe mental disorders or language delay
  • Non French-speaking family
  • Children who does not live with at least one of his/her parents
  • Children whose residence is not compatible with frequent visits at University Hospital of Montpellier
  • Clinical status not compatible with study questionnaires assessment.

Trial locations and contacts

1 site in 1 country.

France1 site
  • Montpellier University Hospital

    Montpellier, 34295

Other trials in France

About this study

Official title: Assessment of a Cognitive-behavioral Group Intervention in Children With Diabetes Mellitus and Their Parents

Diabetes mellitus in children and adolescents is a source of stress and poor quality of life for themselves and their family. Development of adaptive coping strategies may be improved by focused parent and children training. This study assesses a cognitive behavioral treatment (CBT) for children/adolescents with diabetes and their parents in comparison with standard health educational interventions. The investigators main aim is to verify that the CBT program improves overall balance of glycaemia better than phone contact without CBT content (control group). Secondary objectives are expected improvements of health-related quality of life and coping styles in parents and children.

Being tested
"CBT" (Cognitive-Behavioral Therapy), Control (telephonic support without CBT content)
Keywords
diabetes mellitus, glycaemia, cognitive-behavioral treatment, coping, parents, children
Medical subject headings
Diabetes Mellitus, Type 1, Diabetes Mellitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • "CBT" (Cognitive-Behavioral Therapy)Behavioural

  • Control (telephonic support without CBT content)Behavioural

Study groups in NCT02839031
Study groupRoleWhat they receive
"CBT" groupExperimentalNot described
Receives: Behavioral: "CBT" (Cognitive-Behavioral Therapy)
Control groupSham comparatorNot described
Receives: Behavioral: Control (telephonic support without CBT content)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Glycated hemoglobin (HbA1c) level

    Measured: up to 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jul 2016 (estimated)
  2. Study start11 Mar 2015
  3. Primary completion1 Jul 2018
  4. Study completion1 Jul 2018

Why it stopped: Recruitment difficulties (study stopped before the expected 80 inclusions)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
57 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02839031
Sponsor's protocol ID
UF 9369
Acronym
DI-CO
Status last verified
Sep 2019
First submitted
18 Jul 2016
Last updated
6 Sep 2019
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing "CBT" (Cognitive-Behavioral Therapy) in people with Diabetes Mellitus, Type 1, run by University Hospital, Montpellier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 6 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Recruitment difficulties (study stopped before the expected 80 inclusions)). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Glycated hemoglobin (HbA1c) level (time frame: up to 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Sep 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in